.
. the hearings in the european parliament with the participation of the founder of facebook , mark zuckerberg, will pass in the closed mode.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
share on twitter twitter
.